Indeed, we found that anti-PD1 slightly inhibited the tumor growth in Hepa1-6 NC groups, while anti-PD1 combined with SENP3 knockdown significantly suppressed HCC tumor growth (Fig. 8I). Here, SENP3 is linked to hepatocellular carcinoma.